SU1192614A3 - Method of producing 6-hydrazino-pyrido-(2,1-b)-quinozalin-11-on derivatives or salts thereof - Google Patents
Method of producing 6-hydrazino-pyrido-(2,1-b)-quinozalin-11-on derivatives or salts thereof Download PDFInfo
- Publication number
- SU1192614A3 SU1192614A3 SU813301195A SU3301195A SU1192614A3 SU 1192614 A3 SU1192614 A3 SU 1192614A3 SU 813301195 A SU813301195 A SU 813301195A SU 3301195 A SU3301195 A SU 3301195A SU 1192614 A3 SU1192614 A3 SU 1192614A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- group
- alkyl
- hydrogen
- pyrido
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Primary Health Care (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
1one
Изобретение относитс к способу получени новых производных 6-гид- разино-пиридо( 2,1--в)-хиназолин-11она общей формулыThis invention relates to a process for the preparation of new derivatives of 6-hydrazino-pyrido (2,1-b) quinazoline-11one of the general formula
нитрогруппу, карбоксил, нитрил, С Ц - алкоксил, C -С4 алкоксикарбанил , С4-С(ралкил, аминогруппу или гидроксигруппу,nitro, carboxyl, nitrile, C C - alkoxy, C-C4 alkoxycarbanyl, C4-C (ralkyl, amino group or hydroxy group,
9261492614
разбавл ют лед ной уксусной кислотой и затем пр;капывают раствор 2,0 г (о,01 моль) 11-оксо 6,7,8,9-тетрагидро- 1 Н-пиридо-(2 ,1-в)хиназолииа е в 10 мл 50%-ной уксусной кислоты. Реакционную смесь перемешивают при (5) О С в течение 3 ч и затем оставл ют на ночь в холодильнике. Выпавшие кристаллы отфильтровывают и промывают водой. Полученные diluted with glacial acetic acid and then a solution of 2.0 g (o, 01 mol) 11-oxo 6,7,8,9-tetrahydro-1 H-pyrido (2, 1-b) quinazolium-e 10 ml of 50% acetic acid. The reaction mixture was stirred at (5) 0 C for 3 hours and then left in the refrigerator overnight. The precipitated crystals are filtered and washed with water. Received
10 6-фенилгидразоно-11-оксо-6,7,8,9-тетрагидро-11Н-пиридо- (2,1-в)-хиназолины в случае необходимости молгно перекристаллизовать из н-пропа- иола.10 6-phenylhydrazono-11-oxo-6,7,8,9-tetrahydro-11H-pyrido- (2,1-b) -quinazolines, if necessary, instantaneously recrystallize from n-propa-iol.
1515
Полученные соединени указаны в табл. 1.The compounds obtained are listed in Table. one.
и R вместе метилендиоксиили R цand R together methylenedioxy R c
группу;group;
R - водород;г- R is hydrogen; g-
R4 - водород илиС(,С1 -алкил, известных услови х одно-трехкратно, одинаково или по-разному замещенный галогеном, С4-С4.-алкилом, С -С -алкоксилом , фенилоксилом, гидроксилом, нитрогруппой, аминогруппой, циано- группой, карбоксилом, C/j-С -алкокси- карбонилом, С 5-С4-алканоилом, метилендиоксигруппой , трифторметилом, фенилом, С -С -дналкиламиногруппой, фенил, нафтил или пиридил,R4 is hydrogen or C (, C 1 -alkyl, known conditions one or three times, equally or differently substituted by halogen, C 4 -C 4 -alkyl, C-C-alkoxy, phenyloxy, hydroxyl, nitro, amino, cyano, carboxyl, C / j-C-alkoxy-carbonyl, C 5 -C4-alkanoyl, methylenedioxy, trifluoromethyl, phenyl, C-C -dalkylamino, phenyl, naphthyl or pyridyl,
пунктирна лини при определенных услови х имеюща с друга С -С св зь ,the dotted line, under certain conditions, is a C-C bond from a friend,
или их солей, которые могут быть применены .в качестве исходных веществ при получении алкалоидов.or their salts, which can be used as starting materials in the preparation of alkaloids.
Цель изобретени - синтез новых соединений, вл ющихс исходными дл получени алкалоидов.The purpose of the invention is the synthesis of new compounds that are the starting material for the preparation of alkaloids.
Реакцию провод т при ( j - О С в смеси воды с органическим растворителем или в органическом растворителе , смешивающимс с водой.The reaction is carried out at (j-O C in a mixture of water with an organic solvent or in an organic solvent miscible with water.
В качестве инертного органического растворител можно примен ть ал- канкарбоновые кислоты .Alkane carboxylic acids can be used as the inert organic solvent.
Примеры 1-22,Examples 1-22
К смеси из 0,01 моль производного анилина и 5 мл 1: разбавленной 28%ной водной сол ной кислоты медленно , при -5 С и при перемешивании и охлаждении, прикапьшают 0,69 г ,(0,01 моль) нитрата натри в 5 мл воды. Реакционную смесь перемешивают при (-5) в течение 0,5 ч, после чего устанавливают рН реакционной смеси путем добавки ацетата натри равным 4. Реакционную смесьTo a mixture of 0.01 mol of aniline derivative and 5 ml of 1: diluted 28% aqueous hydrochloric acid slowly, at -5 ° C and with stirring and cooling, 0.69 g, (0.01 mol) of sodium nitrate in 5 ml of water. The reaction mixture was stirred at (-5) for 0.5 h, after which the pH of the reaction mixture was adjusted by adding sodium acetate to 4. The reaction mixture
Примеры 23 и 24. Процесс ведут аналогично примерам 1-22, однако вместо 11-оксо-6,7,8,9-тетрагидро-11Н-пиридо- (2,1-в)-хиназолина используют 11-оксо-1,2,3,4,6,7,8-окта-гидро-1 1 Н-пиридо-( 2, 1-в)-хиназолин .Examples 23 and 24. The process is carried out similarly to examples 1-22, however, instead of 11-oxo-6,7,8,9-tetrahydro-11H-pyrido- (2,1-b) -quinazoline use 11-oxo-1,2 , 3,4,6,7,8-octa-hydro-1 1 H-pyrido (2, 1-b) -quinazoline.
Полученные соединени представлены в табл. 1,The compounds obtained are presented in Table. one,
., Примеры 25-28. Процесс ведут аналогично примерам 1-22, однако в качестве исходного вещества в примере 25 используют 2,3,4-триметокси-11-оксо-6 ,7,8,9-тетрагидро- -11Н-пиридо-{2,1-в)-хиназолина, в примере 26 11-оксо-6,7,8,9-тетра- гидро-11 Н-пиридо-( 2,1 -в )-хиназолин-2-карбоновую кислоту, в примере 27 метил- 1-оксо-6,7,8,9-тетрагидро-11Н-пиридо- (2,1-в)-хиназо- ЛИН-2-карбоксилат, а в примере 28 1I-оксо-6,7,8,9-тетрагидро-11Н-пи- ридо-{2,1-в)-хиназолин, ., Examples 25-28. The process is carried out analogously to examples 1-22, however, 2,3,4-trimethoxy-11-oxo-6, 7,8,9-tetrahydro-11H-pyrido {2,1-b ) -quinazoline, in example 26, 11-oxo-6,7,8,9-tetrahydro-11H-pyrido- (2,1 -b) -quinazoline-2-carboxylic acid, in example 27 methyl-1- oxo-6,7,8,9-tetrahydro-11H-pyrido- (2,1-b) -quinazo-LIN-2-carboxylate; in example 28, 1I-oxo-6,7,8,9-tetrahydro- 11H-pyrido- {2,1-b) quinazoline,
Полученные производные 6-фенилгидразоно- 1 1-оксо-6,7,8,9-тетрагид- ро-11Н-пиридо-{2,1-в)-хиназолина указаны в табл. 1.The resulting 6-phenylhydrazono-1 1-oxo-6,7,8,9-tetrahydro-11H-pyrido {2,1-b) -quinazoline derivatives are listed in the table below. one.
Продукты могут перекристаллизо- выватьс из н-пропанола.Products may be recrystallized from n-propanol.
Пример 29. 0,93 г (0,01 моль) анилина раствор ют в5 мл 1:1 разбавленной 38%-ной водной сол ной кислоты при -5 С, после чего при посто нном перемещивании и охлаждении прикапывают 0,69 г (0,01 ммоль) нитрата натри в 5 мл воды. Реакционную смесь перемешивают в течение 0,5 ч при -5 - О С, после чего рН устанавливают равным 4 путем добавки ацетата натри и смесь разбавл ют 10 мл уксусной кис-.Example 29. 0.93 g (0.01 mol) of aniline is dissolved in 5 ml of 1: 1 diluted 38% aqueous hydrochloric acid at -5 ° C, then 0.69 g (0) is added dropwise with constant displacement and cooling. , 01 mmol) of sodium nitrate in 5 ml of water. The reaction mixture is stirred for 0.5 hours at -5 ° C, after which the pH is adjusted to 4 by addition of sodium acetate and the mixture is diluted with 10 ml of acetic acid.
33
лоты. К смеси затем медленно и при интенсивном перемешивании прикапывают раствор 2,28 г (0,01 моль) 6-ч1)ормил-1 1 -оксо-б ,7,8, Э-тетр агид- ро 1Н-пиридо--(2,)-хиназолина в 30 МП уксусной кислоты Реакционную смесь перемепшвают при в течение i ч и- затем оставл ют на ночь в холодильнике. Выделившиес кристаллы отфильтровывают и промывают водой. Получают 3,1 г (91 % б-фенил- гидразоно- 6,7,8,9-тетрагидро-11 -ок со-11Н-пиридо-(2,)-тсиназолингидр ,хлорида с т.пл. 255®С.lots. A solution of 2.28 g (0.01 mol) of 6-h1) Ormyl-1 1 -oxo-b, 7.8, E-tetr agidro 1H-pyrido- (2 ,) - quinazoline in 30 MP of acetic acid. The reaction mixture is stirred for i h and then left overnight in a refrigerator. The precipitated crystals are filtered and washed with water. 3.1 g (91% of b-phenylhydrazono-6,7,8,9-tetrahydro-11-co-11H-pyrido- (2,) - tsinazolinghydr, chloride, mp 255 ° C are obtained.
Вычислено, %: С 63,60; Н 5,04; N 16,48; С1 0,16.Calculated,%: C 63.60; H 5.04; N 16.48; C1 0.16.
c,gH N4001c, gH N4001
Найдено, %: С 63,44; Н 4,98; N 16,59; С1 10,11.Found,%: C 63.44; H 4.98; N 16.59; C1 10.11.
Примеры 30-40. Процесс ведут аналогично примерам 23 и 24, использу в качестве исходных веществ производные Н-оксо-1 ,2,3,4- 6,7,8-октагидро-11Н-пиридо-(2,1-в)хнназолина .Examples 30-40. The process is carried out analogously to examples 23 and 24, using as starting materials derivatives of H-oxo-1, 2,3,4- 6,7,8-octahydro-11H-pyrido- (2,1-in) hnnazoline.
Получают производные 6-фенилгидразоио-11 -юксо-1,2,3,4,6,7,8-октагидро-I1Н-пиридо- (2,1-в)-хиназолинаDerived 6-phenylhydrazio-11-yuco-1,2,3,4,6,7,8-octahydro-I1H-pyrido- (2,1-b) -quinazoline
Вьзделившиес после диазосв зывани кристаллы суспендируютс в 5%- ном растворе гидроокиси натри , после чего водный раствор встр хивают с хлороформом. Высушенный над плав- леньш сульфатом натри хлороформный раствор выпаривают и остаток кристаллизуют.The crystals separated out after diazo-bonding are suspended in 5% sodium hydroxide solution, after which the aqueous solution is shaken with chloroform. The chloroform solution dried over sodium sulfate is evaporated and the residue is crystallized.
Пример 41.О,46 г (0,005 моль) анилина раствор ют в 3 мл I:1 разбавленной 38%-ной сол ной кислоты при -5с, после чегоExample 41.O., 46 g (0.005 mol) of aniline is dissolved in 3 ml of I: 1 diluted 38% hydrochloric acid at -5 s, after which
26142614
при посто нном перемешивании и охлаждении прикапьшают 0,35 г (0,005 моль) нитрита натри в 3 мл воды. Реакционную смесь переметива- с ют при (-5)- в течение 0,5 ч, после чего рН устанавливают равным 4 путем добавки ацетата натри . К смеси медленно прикапывают раствор 6-формил-11-ОКСО-1,2,3,4,6,7,8-окта10 гидро-15 Н-пиридо-(2,1-в)-хиназолина в 15 мл 75%-ной уксусной кислоты. Реакционную смесь перемешивают при температуре ниже в течение 3ч, затем оставл ют на ночь в холоднль- IJ нике и разбавл ют 30 мл воды. Ъыпазшие кристап ш отфильтровывают и про- Ш1вают водой. Получают 1,3 г (73%) 6-фенилгидразиио- 11 -оксо-1,2,3,4,6, 8-ок та гидро- I Н-пиридо- (2., 1 -в) -хина- 20 золингидрохлорида с. т.пл. 242-244 С.under constant stirring and cooling, 0.35 g (0.005 mol) of sodium nitrite is added in 3 ml of water. The reaction mixture was taken up at (-5) for 0.5 h, after which the pH was adjusted to 4 by addition of sodium acetate. A solution of 6-formyl-11-OXO-1,2,3,4,6,7,8-octa-10 hydro-15 H-pyrido- (2,1-b) -quinazoline in 15 ml of 75% - is slowly added dropwise to the mixture. acetic acid. The reaction mixture is stirred at a temperature below for 3 hours, then left overnight in cold water and diluted with 30 ml of water. The crustaceans that are left are filtered and rinsed with water. 1.3 g (73%) of 6-phenylhydrazio-11-oxo-1,2,3,4,6, 8-okta hydro-I H-pyrido- (2., 1-b) -hina-20 are obtained. zoling hydrochloride with. m.p. 242-244 C.
& 1числемо, %: С 63,59; Н N 15,61; С 9,88. &Amp; N,%: C 63.59; H N 15.61; From 9.88.
Найдено, %: С 63,21; Н 6,28; 25 N 5,75; С 9,65.Found,%: C 63.21; H 6.28; 25 N 5.75; From 9.65.
Соединени общей-формулы (I) но- гут быть использованы дл получени новых апкапондов - аналогов рутекап- рина общей формулы по чвперу .Compounds of general formula (I) are used to produce new up-pockets — analogues of rucapprin of general formula for a chopper.
Мочегонное действие новых алкалоидов и известного рутекарпина пр ведено в табл. 2.The diuretic effect of new alkaloids and the well-known rutecarpine is shown in Table. 2
Из приведенных данных следует, что полученные из пр,едлагаемых проI From the data it follows that obtained from the pr, the subject proI
межуточных соединений алкалоиды оказывают значительно более сильное мочегонное действие по сравнению с рутекарпином .interstitial compounds alkaloids have a significantly stronger diuretic effect compared with rutecarpine.
Таблица 2table 2
СамкаFemale
Новый алкалоид .New alkaloid.
СамецMale
Метилцел- Methylcel-
То же 5 лозольвSame 5 lozolv
РутекарпинRutecarpine
13,56 13.56
. 10,05 14,17 10,42. 10.05 14.17 10.42
3,8 3.8
5,05 4,35 6,08 4.75 7,15 4,80 7,105.05 4.35 6.08 4.75 7.15 4.80 7.10
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU801559A HU183173B (en) | 1980-06-24 | 1980-06-24 | Process for producing 6-hydrazono-pyrido-aracket-2,1-b-bracket closed-quinazolin-11-ones |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1192614A3 true SU1192614A3 (en) | 1985-11-15 |
Family
ID=10955013
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU813301195A SU1192614A3 (en) | 1980-06-24 | 1981-06-23 | Method of producing 6-hydrazino-pyrido-(2,1-b)-quinozalin-11-on derivatives or salts thereof |
SU823436303A SU1191449A1 (en) | 1980-06-24 | 1982-05-18 | Derivatives of 6-hydrazonopyrido (2,1-b)quinazolin-11-on as intermediate products in synthesis of indolo(2',3',3,4) pyrido (2,1-b)quinozalin-5-on derivatives possessing diuretic activity |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU823436303A SU1191449A1 (en) | 1980-06-24 | 1982-05-18 | Derivatives of 6-hydrazonopyrido (2,1-b)quinazolin-11-on as intermediate products in synthesis of indolo(2',3',3,4) pyrido (2,1-b)quinozalin-5-on derivatives possessing diuretic activity |
Country Status (25)
Country | Link |
---|---|
JP (1) | JPS5738781A (en) |
AT (1) | AT379393B (en) |
AU (1) | AU544360B2 (en) |
BE (1) | BE889339A (en) |
CA (1) | CA1167842A (en) |
CH (1) | CH648312A5 (en) |
CS (1) | CS296285A2 (en) |
DD (1) | DD160060A5 (en) |
DE (1) | DE3124577A1 (en) |
DK (1) | DK277281A (en) |
ES (1) | ES503266A0 (en) |
FI (1) | FI70897C (en) |
FR (1) | FR2485534A1 (en) |
GB (1) | GB2080291B (en) |
GR (1) | GR74608B (en) |
HU (1) | HU183173B (en) |
IL (1) | IL63061A (en) |
IT (1) | IT1144814B (en) |
NL (1) | NL8102935A (en) |
NO (1) | NO157142C (en) |
PL (2) | PL129623B1 (en) |
PT (1) | PT73248B (en) |
SE (1) | SE441829B (en) |
SU (2) | SU1192614A3 (en) |
YU (1) | YU42722B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ194196A (en) * | 1979-07-17 | 1983-07-15 | Ici Australia Ltd | -(quinoxalin-2-yl(oxy or thio) phen (oxy or ylthio)-alkanoic acid derivatives or precursors |
AT377586B (en) * | 1981-06-30 | 1985-04-10 | Erba Farmitalia | METHOD FOR PRODUCING SUBSTITUTED PYRROLO- (2,1-B) -QUINAZOLINES AND PYRIDO (2,1-B) -QUINAZOLINES |
JPS5987269A (en) * | 1982-11-12 | 1984-05-19 | Nissan Motor Co Ltd | Fuel injection valve |
JPS61126367A (en) * | 1984-11-24 | 1986-06-13 | Mitsubishi Heavy Ind Ltd | Fuel injection device |
JPS61129457A (en) * | 1984-11-27 | 1986-06-17 | Mitsubishi Heavy Ind Ltd | Multi-fuel-valve injector |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU178496B (en) * | 1977-12-29 | 1982-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity |
-
1980
- 1980-06-24 HU HU801559A patent/HU183173B/en not_active IP Right Cessation
-
1981
- 1981-06-09 IL IL63061A patent/IL63061A/en unknown
- 1981-06-18 CS CS852962A patent/CS296285A2/en unknown
- 1981-06-18 NL NL8102935A patent/NL8102935A/en not_active Application Discontinuation
- 1981-06-22 FR FR8112209A patent/FR2485534A1/en active Granted
- 1981-06-22 ES ES503266A patent/ES503266A0/en active Granted
- 1981-06-22 GR GR65305A patent/GR74608B/el unknown
- 1981-06-23 NO NO812143A patent/NO157142C/en unknown
- 1981-06-23 DE DE19813124577 patent/DE3124577A1/en not_active Withdrawn
- 1981-06-23 SU SU813301195A patent/SU1192614A3/en active
- 1981-06-23 CH CH4143/81A patent/CH648312A5/en not_active IP Right Cessation
- 1981-06-23 AT AT0277081A patent/AT379393B/en not_active IP Right Cessation
- 1981-06-23 PT PT73248A patent/PT73248B/en unknown
- 1981-06-23 SE SE8103940A patent/SE441829B/en not_active IP Right Cessation
- 1981-06-23 PL PL1981231826A patent/PL129623B1/en unknown
- 1981-06-23 FI FI811970A patent/FI70897C/en not_active IP Right Cessation
- 1981-06-23 YU YU1564/81A patent/YU42722B/en unknown
- 1981-06-23 CA CA000380416A patent/CA1167842A/en not_active Expired
- 1981-06-23 DK DK277281A patent/DK277281A/en not_active Application Discontinuation
- 1981-06-23 BE BE0/205178A patent/BE889339A/en not_active IP Right Cessation
- 1981-06-23 IT IT67869/81A patent/IT1144814B/en active
- 1981-06-23 GB GB8119298A patent/GB2080291B/en not_active Expired
- 1981-06-23 PL PL1981235214A patent/PL129635B1/en unknown
- 1981-06-23 AU AU72081/81A patent/AU544360B2/en not_active Ceased
- 1981-06-24 JP JP9813381A patent/JPS5738781A/en active Pending
- 1981-06-26 DD DD81231194A patent/DD160060A5/en not_active IP Right Cessation
-
1982
- 1982-05-18 SU SU823436303A patent/SU1191449A1/en active
Non-Patent Citations (1)
Title |
---|
Phyllips R. The Japp-Klingemann reaction. - Organic Reactions. - New York, v. 10, p. 143-178. * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU733516A3 (en) | Method of preparing quinazolon derivatives or their salts | |
SU727142A3 (en) | Method of preparing substituted 1-sulfonidebenzimidazoles | |
WO1993016076A1 (en) | 3-(1h^_-tetrazol-5-yl)-4h^_-pyrido[1,2-a^_]pyrimidine-4-ones, pharmaceutical compositions containing the same and the preparation thereof | |
SU893134A3 (en) | Method of preparing imidazo /2,1-b/ thiazoline-or thiazine derivatives in form of mixture or individual isomers or their acid-additive salts | |
SU1192614A3 (en) | Method of producing 6-hydrazino-pyrido-(2,1-b)-quinozalin-11-on derivatives or salts thereof | |
SU481155A3 (en) | Production method - (furyl-methyl) morphinans | |
JPH0141637B2 (en) | ||
RU2042678C1 (en) | Method of synthesis of 6,7-dichloro-1,5-dihydroimidazo-[2,1-b]-quinazoline-2-(3h)-one, intermediates for their synthesis and a method of their synthesis | |
US3960847A (en) | 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof | |
SU1579459A3 (en) | Method of obtaining derivatives of 1-methylaminoquinolinecarboxylic acid or their salts connecting pharmaceutically acceptable acids | |
SU1230468A3 (en) | Method of producing derivatives of quinoxaline-1,4-dioxide | |
EP0138490B1 (en) | 4-alkyl methylenedioxy-2-1[H]-quinazolinones | |
SU419028A3 (en) | METHOD OF OBTAINING 2- | |
JPH0782498A (en) | Bisazo compound | |
PL139429B1 (en) | Process for preparing novel,base-substituted 4-phenyl-4,5,6,7-tetrahydro-thieno/2,3-c/pyridines | |
SU1220570A3 (en) | Method of producing derivatives of quinoxalyndioxide | |
US3953493A (en) | Substituted sulfonamide derivatives as anthelmintic agents | |
US2524802A (en) | Hydroxybenzenesulfonamidopyridazines and preparation of same | |
US4066644A (en) | Pyrazolo [1,5-a]pyrido[3,2-e]pyrimidine-7-carboxylic acid heterocyclic derivatives | |
SU980622A3 (en) | Process for producing derivatives of pyrido(1,2,a)pyrimidine, their optical isomermers or their hydrates or salts | |
Monge‐Vega et al. | Synthesis of some new derivatives of 4‐hydrazino‐5H‐pyridazino [4, 5‐b] indole | |
KR840001286B1 (en) | Process for preparation of 2-imidazaline derivatives | |
SU626694A3 (en) | Method of producing benzimidazole derivatives or their salts | |
US3277096A (en) | Process for the preparation of aminohalogeno isoquinolines | |
SU1705287A1 (en) | Derivatives of 2-amino-1,2,3,4-tetrahydroisoquinoline with saluretic effect |